Merck
  • Home
  • Search Results
  • Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.

Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.

Analytica chimica acta (2014-12-04)
Lucie Nováková, Marco Rentsch, Alexandre Grand-Guillaume Perrenoud, Raul Nicoli, Martial Saugy, Jean-Luc Veuthey, Davy Guillarme
ABSTRACT

The potential and applicability of UHPSFC-MS/MS for anti-doping screening in urine samples were tested for the first time. For this purpose, a group of 110 doping agents with diverse physicochemical properties was analyzed using two separation techniques, namely UHPLC-MS/MS and UHPSFC-MS/MS in both ESI+ and ESI- modes. The two approaches were compared in terms of selectivity, sensitivity, linearity and matrix effects. As expected, very diverse retentions and selectivities were obtained in UHPLC and UHPSFC, proving a good complementarity of these analytical strategies. In both conditions, acceptable peak shapes and MS detection capabilities were obtained within 7 min analysis time, enabling the application of these two methods for screening purposes. Method sensitivity was found comparable for 46% of tested compounds, while higher sensitivity was observed for 21% of tested compounds in UHPLC-MS/MS and for 32% in UHPSFC-MS/MS. The latter demonstrated a lower susceptibility to matrix effects, which were mostly observed as signal suppression. In the case of UHPLC-MS/MS, more serious matrix effects were observed, leading typically to signal enhancement and the matrix effect was also concentration dependent, i.e., more significant matrix effects occurred at the lowest concentrations.

MATERIALS
Product Number
Brand
Product Description

Metolazone, European Pharmacopoeia (EP) Reference Standard
Metolazone for system suitability, European Pharmacopoeia (EP) Reference Standard
Clopamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ammonium formate solution, BioUltra, 10 M in H2O
Supelco
Ammonium formate solution, 10 mM in H2O, suitable for HPLC
Furosemide, European Pharmacopoeia (EP) Reference Standard
USP
Furosemide, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Metolazone, ≥98% (HPLC), solid
Supelco
Furosemide, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Indapamide, analytical standard, for drug analysis
Sigma-Aldrich
Bumetanide, ≥98%
Sigma-Aldrich
Furosemide
Supelco
Bendroflumethiazide, analytical standard
Indapamide, European Pharmacopoeia (EP) Reference Standard
USP
Indapamide, United States Pharmacopeia (USP) Reference Standard
Bendroflumethiazide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ethacrynic acid, ≥97% (HPLC)
Ethacrynic acid, European Pharmacopoeia (EP) Reference Standard
Furosemide for peak identification, European Pharmacopoeia (EP) Reference Standard
Bumetanide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Argon-40Ar, 99.95 atom %
Sigma-Aldrich
Tetrahydrofuran, ACS reagent, ≥99.0%, contains 250 ppm BHT as inhibitor
Clopamide for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Tetrahydrofuran, contains 250 ppm BHT as inhibitor, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.9%
Sigma-Aldrich
Tetrahydrofuran, ReagentPlus®, ≥99.0%, contains 250 ppm BHT as inhibitor
Sigma-Aldrich
Ammonium formate, reagent grade, 97%
Sigma-Aldrich
Tetrahydrofuran, inhibitor-free, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Tetrahydrofuran, contains 250 ppm BHT as inhibitor, ACS reagent, ≥99.0%
Sigma-Aldrich
Tetrahydrofuran, anhydrous, ≥99.9%, inhibitor-free
Supelco
Tetrahydrofuran, analytical standard